Related Experiment Video
Updated: Mar 15, 2026

Bacterial Artificial Chromosomes: A Functional Genomics Tool for the Study of Positive-strand RNA Viruses
Published on: December 29, 2015
Knowledge Obtained from an Elderly Case of Japanese Encephalitis
Kyoko Itoh1, Kazuhide Iwamoto, Yu Satoh
1Department of Pathology & Applied Neurobiology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Japan.
Japanese encephalitis (JE) vaccination has lowered infection rates, but antibody prevalence remains low in young children and middle-aged adults. A severe encephalitis case highlights the need for continued vigilance and vaccination, especially for at-risk groups.
Area of Science:
- Virology
- Immunology
- Epidemiology
Background:
- The widespread use of the Japanese encephalitis (JE) vaccine has led to a decrease in annual JE infections across Japan.
- Despite vaccination efforts, a significant portion of the population, including children aged 3-4 and individuals in their 40s and 50s, exhibit low neutralizing antibody prevalence (around 20%).
Observation:
- This report details a confirmed case of JE in an adult male.
- Diagnosis was established through multi-virus real-time polymerase chain reaction on brain tissue biopsy and supporting serological tests.
Findings:
- The study confirms a case of Japanese encephalitis diagnosed via advanced molecular and serological techniques.
- This case underscores the persistent risk of JE even with existing vaccination programs.
Implications:
- Japanese encephalitis should be considered in severe encephalitis cases of unknown origin.
- Continued vaccination is crucial for protecting vulnerable populations, particularly children and middle-aged individuals, against JE.
- Maintaining high vaccination coverage is essential to prevent future outbreaks and manage the risk in susceptible demographics.
More Related Videos
09:37Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
08:36Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Pharmacodynamics in Geriatric Patients: Effects of Age
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...